Long-acting non-depolarising neuromuscular blocker
Pancuronium bromide
Adult dose
Dose: 50–100 micrograms/kg IV
Route: IV
Frequency: per induction
Dose adjustments
Renal
Reduce — predominantly renally excreted
Clinical pearls
- Long-duration paralysis (60–120 min); largely superseded by atracurium/cisatracurium/rocuronium
- Reverse with neostigmine + glycopyrronium
Contraindications
- Hypersensitivity
Side effects
- Tachycardia (vagolytic)
- Hypertension
- Prolonged blockade in renal/hepatic impairment
Interactions
- Aminoglycosides
- Magnesium
- Volatile anaesthetics
- β-blockers
Monitoring
- Train-of-four
- Cardiovascular
Reference: BNF; AAGBI; https://bnf.nice.org.uk/drugs/pancuronium-bromide/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Train-of-Four (TOF) Neuromuscular Monitoring · Neuromuscular Blockade
- Corrected QT Interval (Bazett) · ECG
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
- MAGGIC Heart Failure Risk Score · Heart Failure
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- New Ballard Score — Gestational Age Assessment · Gestational Age